Results 131 to 140 of about 203,608 (213)

Development and Validation of a New LC-MS/MS Method for Simultaneous Quantification of Ivacaftor, Tezacaftor and Elexacaftor Plasma Levels in Pediatric Cystic Fibrosis Patients. [PDF]

Pharmaceuticals (Basel)
Mancini A, Simeoli R, Cristiani L, Cairoli S, Ciciriello F, Boni A, Alghisi F, Rossi C, Antonetti G, Vici CD, Fiocchi AG, Cutrera R, Goffredo BM.   +12 more
europepmc   +1 more source

Deep learning radiomics: Redefining precision oncology through noninvasive insights into the tumor immune microenvironment. [PDF]

World J Gastrointest Oncol
Tez M.
europepmc   +1 more source

Comparison of the Effect of CFTR Modulators <i>elexacaftor</i>/<i>tezacaftor</i>/<i>ivacaftor</i> and <i>lumacaftor</i>/<i>ivacaftor</i> via Serum Human Epididymis Protein 4 Concentration in <i>p.Phe508del-CFTR</i> Homozygous Cystic Fibrosis Patients. [PDF]

J Clin Med
Pócsi M, Fila L, Péterfia C, Halász A, Szanto TG, Mészáros B, Major J, Laki I, Szabó H, Panyi G, Balogh I, Amaral MD, Macek M, Nagy B.   +13 more
europepmc   +1 more source

Preoperative malignancy risk assessment in pancreatic cystic neoplasms using clinical and laboratory parameters. [PDF]

World J Gastrointest Surg
Martli HF, Acehan F, Şimşek A, Şahingöz E, Sürel AA, Er S, Tez M.   +6 more
europepmc   +1 more source

Frequency Response Analysis of MEMS Comb-Drive Resonator Integrated With a Polymer Thin Film Layer

Electrica
Serdar Tez, Mehmet Kaya
doaj   +1 more source

Antisense oligonucleotide targeting the E3 ligase RFFL potentiates CFTR modulator efficacy in CF primary bronchial epithelial cells. [PDF]

Mol Ther Nucleic Acids
Hinata D, Kai Y, Fukuda R, Kamada Y, Kasahara Y, Sasaki K, Yoshida T, Obika S, Inoue T, Okiyoneda T.   +9 more
europepmc   +1 more source

Identification of predictive factors for clinical remission and comparison of 3 definitions in Japanese patients with severe asthma treated with biologics. [PDF]

J Allergy Clin Immunol Glob
Numata T, Saito S, Okuda K, Miyagawa H, Yoshida M, Takekoshi D, Ito S, Minagawa S, Ishikawa T, Hara H, Araya J.   +10 more
europepmc   +1 more source

Psychological impact of genetic eligibility for CFTR modulator therapy in children with cystic fibrosis and their parents. [PDF]

Eur J Pediatr
Oztosun B, Durcan G, Gulumser SB, Altug D, Gunal B, Anac E, Yavuz M, Cokugras H, Dogangun B, Kilinc Sakalli AA.   +9 more
europepmc   +1 more source

The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review. [PDF]

Diabetologia
Sharpe H, Lam GY.
europepmc   +1 more source

A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring. [PDF]

Molecules
D'Atri V, Corrado F, Versace F, Saldanha SA, Mercier T, Guidi M, Thoueille P, Blanchon S, Koutsokera A, Vogeser M, Marzolini C, Girardin F, Mitropoulou G, Balmpouzis Z, Rochat I, Sauty A, Decosterd LA, Choong E.   +17 more
europepmc   +1 more source